You are here

Home

Carrera Bioscience Inc.

Company Information
Address
950 DANBY RD STE 106
ITHACA, NY 14850-5714
United States
Information

UEI: N/A

# of Employees: 2
Ownership Information

HUBZone Owned: No

Socially and Economically Disadvantaged: Yes

Woman Owned: Yes

Award Charts




Award Listing

  • Record 1 TO 5

  1. Virus specific diagnosis of hepatitis infection using isothermal amplification in resource poor settings

    Amount: $604,500.00

    There is a pressing need to detect and differentiate all forms of viral hepatitis in patient samples as a point of care assay The existing FDA cleared PCR based HBV and HCV diagnosis kits require sop ...

    SBIRPhase II2016Department of Health and Human Services Centers for Disease Control and Prevention

  2. Specific Detection of Hepatitis B Virus cccDNA from Patient Sera Plasma

    Amount: $149,999.00

    Hepatitis B Virus HBV causes acyte liver infection with of the patients worldwide develop chronic infection cirrhosis and liver cancer that causes tremendous health and economic impact The ...

    SBIRPhase I2016Department of Health and Human Services Centers for Disease Control and Prevention

  3. Virus specific diagnosis of hepatitis infection using isothermal amplification in resource poor settings

    Amount: $150,000.00

    There is a pressing need to detect and differentiate all forms of viral hepatitis in patient samples as a point of care assay The existing FDA cleared PCR based HBV and HCV diagnosis kits require s ...

    SBIRPhase I2015Department of Health and Human Services Centers for Disease Control and Prevention

  4. Concurrent identification of Natural Antibiotics-Producing Gene Clusters and Culture Conditions

    Amount: $149,993.10

    Modern metagenomics studies on diverse microbiomes revealed immense repertoires of potential natural products/antibiotics to be tapped into.However, identifying such secondary metabolites (SMs) direct ...

    SBIRPhase I2015Department of Defense Office for Chemical and Biological Defense

  5. Biomimetic Material Solutions for the Stabilization of Labile Reagents

    Amount: $150,000.00

    ABSTRACT: A platform (PHA-fuse) for the stabilization of diagnostic and therapeutic reagents will be established based upon the polymer, polyhydroxyalkanoate (PHA). Fusions of a target molecule to PHA ...

    STTRPhase I2015Department of Defense Air Force
US Flag An Official Website of the United States Government